Compare RNXT & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | RFM |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 79.7M |
| IPO Year | 2021 | 2019 |
| Metric | RNXT | RFM |
|---|---|---|
| Price | $1.16 | $13.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.13 | N/A |
| AVG Volume (30 Days) | ★ 360.8K | 23.5K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $244.84 | N/A |
| Revenue Next Year | $195.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $12.52 |
| 52 Week High | $2.59 | $15.03 |
| Indicator | RNXT | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 36.64 | 59.25 |
| Support Level | $1.09 | $13.23 |
| Resistance Level | $1.30 | $14.74 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 36.72 | 75.37 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.